白介素4-绿脓杆菌外毒素重组免疫毒素的构建与活性研究

白介素-4受体（IL-4R）在实体瘤和血癌等许多肿瘤细胞表面表达量很高构建导向IL-4R的免疫毒素，是研究肿瘤治疗的一个重要方向。天然IL-4分子N末端和C末端含有很多与受体结合的活性位点，为了降低连接蛋白毒素时对这些位点的影响，将天然IL-4分子的N端和c端用寡肚GGNGG相连，并在非活性部位形成新的开口，构建了cpIL-4；为了进一步提高cpIL-4与IL-4R的亲和力，通过重叠PCR引入13位点突变，得到cpIL-4（13D）；为了增强IL-4免疫毒素对淋巴细胞的选择性，在121位引入点突变，得到cpIL-4（13D121E）。将上述三种重组IL-4分子分别于大肠杆菌表达系统进行表达。ELISA分析表明，三种重组蛋白均可与人IL-4抗体特异性结合。由于PE的DNA序列的GC含量很高，很难用常规手段进行改造，本文采用特殊条件的PCR反应和酶切反应进行绿脓杆菌外毒素PE的改造，得到PE38KDEL，并于大肠杆菌表达系统进行表达。其特点是分子量较小，不含结合区，C末端氨基酸KDEL有利于提高其跨膜能力和细胞毒作用。将靶向分子分别与毒素分子相连，得到三种免疫毒素：cpIL4-PE38KDEL，cpIL4（13D）-PE38KDEL，cpIL4（13D121B）-PE38KDEL。将之分别于表达载体pET32a（＋）进行表达，目的蛋白表达量均约为菌体总蛋白的30％。western blotting分析表明，诱导后表达的三种IL-4免疫毒素均可与hIL-4抗体特异性结合。采用Ni-NTA亲和层析和阴离子交换层析纯化上述三种IL-4免疫毒素，纯度均在95％以上。用MTT法检测其细胞毒作用，结果显示，免疫毒素cpIL4（13D）-PE38KDEL可特异性地靶向产生IL-4R的细胞株，＿且其活性与未突变的免疫毒素cpIIL4-PE38KDEL相比有2-3倍的提高；免疫毒素cpIL4（13D121E）-PE38KDEL对表达I型IL-4R的淋巴瘤细胞结合力较强，对表达II型IL-4R的内皮细胞结合力较弱，因此对淋巴瘤具有一定的选择性，这对于提高药物疗效，降低血管渗漏症等毒副作用具有重要意义。

Interaction between human interleukin-16 and CD4 receptor of HIV-1

AIM: To study the interaction between human interleukin-16 (IL-16) and the receptor CD4 (T-lymphocyte differentiation antigen) of human immunodeficiency virus type 1 (HIV-1). METHODS: Two structurally con served regions (SCRs) of human IL-16 were built by the SYBYL/Biopolymer module using the corresponding transmembrane (TM) domain of human interleukin-1 (HIL-4) and HIL-2 as the templates. The coordinates for amino-terminal residue sequence, carboxyl-terminal residue sequences, and cytoplasm loops were generated using Biopolymer's LOOP SEARCH algorithm. RESULTS: HIL-16 first formed a homodimer, then contacted with CD4 dimer further forming a dimeric complex. Subsequently, the dimeric complex constructed the tetrameric complex by two disulfide bridges between the cysteines of HIL-16 (Cys31-Cys31). CONCLUSION: The interaction model is useful to propose the action mechanism of HIL-16 and is beneficial for rational designing of novel anti-HIV drugs.

Toll-like receptor 4 signaling pathway can be triggered by grass carp reovirus and Aeromonas hydrophila infection in rare minnow Gobiocypris rarus

Toll-like receptor 4 (TLR4) is critical for LPS recognition and cellular responses. It also recognizes some viral envelope proteins. Detection mostly results in the inflammation rather than specific antiviral responses. However, it's unclear in fish. In this report, a TLR4 gene (named as GrTLR4b) was cloned and characterized from rare minnow Gobiocypris rarus. The full length of GrTLR4b cDNA consists of 2766 nucleotides and encodes a polypeptide of 818 amino acids with an estimated molecular mass of 94,518 Da and a predicted isoelectric point of 8.41. The predicted amino acid sequence comprises a signal peptide, six leucine-rich repeat (LRR) motifs, one leucine-rich repeat C-terminal (LRRCT) motif, followed by a transmembrane segment of 23 amino acids, and a cytoplasmic region of 167 amino acids containing one Toll - interleukin 1 - receptor (TIR) motif. It's closely similar to the zebrafish (Danio rerio) TLR4b amino acid sequence with an identity of 77%. Quantitative RT-PCR analysis showed GrTLR4b mRNA was constitutive expression in gill, heart, intestine, kidney, liver, muscle and spleen tissues in healthy animals and up-regulated by viruses and bacteria. After being infected by grass carp reovirus or Aeromonas hydrophila, GrTLR4b expressions were up-regulated from 24 h post-injection and lasted until the fish became moribund (P < 0.05). These data implied that TLR4 signaling pathway could be activated by both viral and bacterial infection in rare minnow. (C) 2009 Elsevier Ltd. All rights reserved.

Purification and characterization of recombinant truncated human interleukin-11 expressed as fusion protein in Escherichia coli

Mature human interleukin-11 (HuIL-11) is a cytokine consisting of 178 amino acid residues that results from scission of the N-terminal signal peptide, consisting of 21 amino acid residaues, from the corresponding nascent polypeptide. A DNA fragment encoding a truncated HuIL-11 (trHuIL-11), with an additional 5 amino acid residues removed from the N-terminus, was cloned into vector pGEX-2T between the BamHI site and the EcoRI site. Upon transformation with Escherichia coli BL21, the construct over-produced a glutathione S-transferase (GST)-fused protein in a soluble form after IPTG induction. The fusion protein was initially fractionated with butyl-Sepharose 4 fast flow column and by affinity chromatography using a GSH-Sepharose 4B column. On-site enzymatic release with thrombin gave the target protein at 96% purity as judged by SDS-PAGE and HPLC. Expression of the interleukin as a GST-fused protein thus greatly improved downstream processing. Subsequent biological activity assay suggested that trHuIL-11 had similar activity profile to the naturally produced sample and may be a promising candidate for further development as biopharmaceutical.